You are here: Home » Current Affairs » Coronavirus » News
Business Standard

3rd phase of vaccination for people above 50 likely to begin in March: Govt

The third phase of vaccination against the coronavirus is likely to commence in March and will cover 27 crore people aged 50 years and above and those with co-morbidities

Topics
Coronavirus Vaccine | India vaccination | Health Ministry

Press Trust of India  |  New Delhi 

Israel, the country with the highest vaccination rate in the world, is headed for 75 per cent coverage in just two months

The third phase of vaccination against the coronavirus is likely to commence in March and will cover 27 crore people aged 50 years and above and those with co-morbidities, Health Minister Harsh Vardhan said in on Friday.

Replying to questions on vaccines and the vaccination drive against the coronavirus during the Question Hour, Vardhan said nearly five million people have been inoculated in the country so far.

He added that the vaccination drive for frontline workers has begun this week.

"In coming days, 27 crore people who are of above 50 years of age and those under 50 with co-morbidities will be vaccinated," Vardhan said.

The vaccination drive began on January 16, starting with healthcare workers and then the frontline workers, both estimated to be around three crore.

"After the completion of first and second phases, the third phase could be launched from any week next month," Vardhan said.

He added that the third phase will cover people above the age of 50.

"It is not possible to give an exact date, but we estimate that this process can start in the second, third or the fourth week of March," he said.

Vardhan said the finance minister has allocated Rs 35,000 crore for vaccination in the budget and she has assured that it could be increased if required.

He said two vaccines -- Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech -- have been approved for emergency use authorisation.

Besides these, work is in progress on seven vaccines. Of the seven, three vaccines are in phase 3 clinical trial stage. Two vaccines are in phase 1 and 2 clinical trial stages and the remaining two are in advanced pre-clinical stage.

He said India has received requests for vaccines from 22 countries. These countries include Afghanistan, Algeria, Bangladesh, Bhutan, Brazil, Egypt, Kuwait, Maldives, Mauritius, Morocco, Mongolia, Myanmar, Nepal, Nicaragua, Oman, Saudi Arabia, Seychelles, South Africa and the UAE. There is also request from the Pacific Island countries, he said.

Vaccines have already been given to 15 countries through grant assistance and contracted doses.

He said 56 lakh doses have been sent through grants and five lakh doses through contract.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Fri, February 05 2021. 20:35 IST
RECOMMENDED FOR YOU